Literature DB >> 29247992

Metabolic regulation of NLRP3.

Mark M Hughes1, Luke A J O'Neill1.   

Abstract

A shift in our understanding of macrophage biology has come about as a result of recent discoveries in the area of metabolic reprogramming of macrophages. The NLRP3 inflammasome drives the activation of caspase-1, leading to the production of IL-1β, IL-18, and a type of cell death termed pyroptosis. The NLRP3 inflammasome has been shown to sense metabolites such as palmitate, uric acid, and cholesterol crystals and is inhibited by ketone bodies produced during metabolic flux. The NLRP3 inflammasome has also been shown to be regulated by mitochondrial reactive oxygen species and components of glycolysis, such as Hexokinase. Here, we review these findings and discuss their importance for inflammation and furthermore discuss potential therapeutic benefits of targeting NLRP3.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Krebs cycle; NLRP3; glycolysis; inflammasome; inflammation; metabolism

Mesh:

Substances:

Year:  2018        PMID: 29247992     DOI: 10.1111/imr.12608

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  77 in total

Review 1.  Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis.

Authors:  Ira Tabas; Karin E Bornfeldt
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 2.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

3.  An association between mitochondria and microglia effector function. What do we think we know?

Authors:  G Jean Harry; Gabrielle Childers; Sahana Giridharan; Irisyunuel Lopez Hernandes
Journal:  Neuroimmunol Neuroinflamm       Date:  2020-06-16

Review 4.  Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity.

Authors:  Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

5.  Metabolic Regulation of Inflammasome Activity Controls Embryonic Hematopoietic Stem and Progenitor Cell Production.

Authors:  Jenna M Frame; Caroline Kubaczka; Timothy L Long; Virginie Esain; Rebecca A Soto; Mariam Hachimi; Ran Jing; Arkadi Shwartz; Wolfram Goessling; George Q Daley; Trista E North
Journal:  Dev Cell       Date:  2020-08-17       Impact factor: 12.270

Review 6.  The NLRP3 inflammasome: molecular activation and regulation to therapeutics.

Authors:  Karen V Swanson; Meng Deng; Jenny P-Y Ting
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

Review 7.  Increasing complexity of NLRP3 inflammasome regulation.

Authors:  Julien Moretti; J Magarian Blander
Journal:  J Leukoc Biol       Date:  2020-06-12       Impact factor: 4.962

8.  Promotion of Anti-Tuberculosis Macrophage Activity by L-Arginine in the Absence of Nitric Oxide.

Authors:  Melanie C McKell; Rebecca R Crowther; Stephanie M Schmidt; Michelle C Robillard; Rachel Cantrell; Maria A Lehn; Edith M Janssen; Joseph E Qualls
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 9.  From Mitochondria to Atherosclerosis: The Inflammation Path.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; José A Sánchez-Alcázar
Journal:  Biomedicines       Date:  2021-03-05

10.  Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome.

Authors:  Katharina Cosker; Anna Mallach; Janhavi Limaye; Thomas M Piers; James Staddon; Stephen J Neame; John Hardy; Jennifer M Pocock
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.